ORF28-06 - Efficacy and Safety of Once-Daily Oral Paltusotine in Patients with Acromegaly: Up to 2 Years in the PATHFNDR-1 and PATHFNDR-2 Open-Label Extension Studies

Oral Abstract Presenter(s)

• MG

  Monica R. Gadelha, MD, PhD

  Centro de Pesquisa Clínica, Instituto Estadual do Cérebro Paulo Niemeyer
  Rio de Janeiro, Brazil

Co-Author(s)

• AC

  Alessandra Casagrande, MD, PhD

  Crinetics Pharmaceuticals, Inc.
  San Diego, California, United States
• 

  Christian J. Strasburger, MD (he/him/his)

  Senior Professor
  Charite Universitaetsmedizin Berlin, Germany, Campus Mitte
  Berlin, Germany
• MB

  Martin Bidlingmaier, MD

  Department of Medicine IV, LMU University Hospital
  Munich, Germany
• AE

  Atanaska Elenkova, MD, PhD

  Medical University-Sofia, USHATE “Acad. Ivan Penchev”
  Sofia, Bulgaria
• PS

  Peter J. Snyder, MD

  University of Pennsylvania
  Philadelpiha, Pennsylvania, United States
• MG

  Mirtha A. Guitelman, MD

  Hospital Carlos G. Durand
  Buenos Aires, Argentina
• CB

  Cesar L. Boguszewski, MD, PhD

  Endocrine Division (SEMPR), University Hospital, Federal University of Paraná
  Curitiba, Brazil
• MB

  Michael Buchfelder, MD, PhD

  University Hospital Erlangen
  Erlangen, Germany
• IS

  Ilan Shimon, MD

  Rabin-Beilinson Medical Center
  Petach Tikva, Israel
• GR

  Gerald Raverot, MD,PhD

  Professor, of Medicine, Chief of Department
  Hospices Civils de Lyon
  Lyon Cedex 03, FRANCE
• RJ

  Raquel S. Jallad, MD

  University of São Paulo Medical School
  São Paulo, Brazil
• EH

  Erika Hubina, MD

  Central Hospital of Northern Pest - Military Hospital
  Budapest, Hungary
• PF

  Pouneh K. Fazeli, MD, MPH

  University of Pittsburgh Medical Center
  Pittsburgh, Pennsylvania, United States
• MF

  Maria Fleseriu, MD

  Oregon Health & Science University
  Portland, Oregon, United States
• YZ

  Yining Zhao, none

  FAU University of Erlangen-Nuremberg
  Erlangen, Germany
• 

  Beatriz Soares, MD, PhD

  Professor
  Federal University of Minas Gerais
  Belo Horizonte, Minas Gerais, Brazil
• MT

  Miklos Toth, MD, PhD, DSc

  Semmelweis University
  Budapest, Hungary
• EM

  Emese Mezősi, MD, PhD, DSc

  Clinical Center, University of Pécs Medical School
  Pécs, Hungary
• MD

  Mirjana Doknic, MD

  Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade
  Belgrade, Serbia
• BH

  Beibei Hu, MS

  Crinetics Pharmaceuticals, Inc.
  San Diego, California, United States
• PT

  Peter J. Trainer, MD

  Crinetics Pharmaceuticals
  San Diego, California, United States
• BB

  Beverly M. K. Biller, MD, PhD

  Neuroendocrine and Pituitary Tumor Clinical Center, Massachusetts General Hospital
  Boston, Massachusetts, United States